The world of targeted therapies in kidney cancers: pitfalls, tips and tricks

In the past few years, metastatic renal cell carcinoma prognosis was improved by the development of molecular targeted therapies (TTs). At the metastatic stage, the tolerance to treatment is a major concern, not only because of the challenge of the efficacy/toxicity ratio improvement but also becaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallard, Alexis, Trone, Jane-Chloé, Langrand-Escure, Julien, Espenel, Sophie, Guy, Jean-Baptiste, Rancoule, Chloé, Xia, Yaoxiong, El Meddeb Hamrouni, Anis, Ben Mrad, Majed, Magné, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344426/
https://www.ncbi.nlm.nih.gov/pubmed/28424553
http://dx.doi.org/10.2147/OTT.S127919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344426/
https://www.ncbi.nlm.nih.gov/pubmed/28424553
http://dx.doi.org/10.2147/OTT.S127919

Ejemplares similares